Optimal DNA vaccine efficacy requires circumventing several obstacles, including lowimmunogenicity, a need for adjuvant, and the costs of purifying injection grade plasmid DNA.Bacterial delivery of plasmid DNA may provide an efficient and low-cost alternative to plasmidpurification and injection. Also, the bacterial vector may exhibit potential as an immune adjuvantin vivo. Thus, we elected to examine the use of cell-wall-deficient
Listeria monocytogenes as aDNA delivery vehicle in vitro. First, the
D-alanine-deficient (
dal-dat)
L. monocytogenes strainDP-L3506, which undergoes autolysis inside eukaryotic host cells in the absence of
D-alanine,was transformed with a plasmid encoding green fluorescent protein (GFP) under control of theCMV promoter (pAM-EGFP). Then COS-7 and MC57G cell lines were infected with thetransformed DP-L3506 at various multiplicities of infection (MOI) in the presence or absenceof
D-alanine. Subsequent GFP expression was observed in both cell lines by 24 h post-infectionwith DP-L3506(pAM-EGFP). Notably, no GFP positive cells were observed when
D-alaninewas omitted. Although transfection efficiency initially increased as a result of
D-alaninesupplementation, high concentration or long-term supplementation led to sustained bacterialgrowth that killed the infected host cells, resulting in fewer GFP-expressing cells. Thus, efficientDNA delivery by transformed bacteria must balance bacterial invasion and survival with targetcell health and survival.